Zhu J D
Chester Beatty Laboratories, Institute of Cancer Research, London, UK.
FEBS Lett. 1994 Feb 21;339(3):243-8. doi: 10.1016/0014-5793(94)80424-9.
The myeloid-lineage specific enhancer at 3.4-3.1 kb upstream of the mouse myeloperoxidase gene [1] has been further characterised. In vitro DNase I footprinting experiments revealed three protected sequences (FT-I, -II and -III) in the enhancer, associated with the proteins that are enriched in WEHI 3BD+ cells, at which the MPO gene is highly expressed; but not in two non-MPO expressing lymphocytic cell lines. Site-specific mutations at each element severely reduced the level of the reporter gene activity in a non-additive manner. This is parallel with either abolishment or alteration of the corresponding wild-type protein-DNA interaction in vitro. Consideration of the sequence motifs present in the enhancer suggests that the cis-elements defined as the in vitro DNase I footprints are likely to be novel.
小鼠髓过氧化物酶基因上游3.4 - 3.1 kb处的髓系特异性增强子已得到进一步表征。体外DNase I足迹实验揭示了增强子中的三个受保护序列(FT-I、-II和-III),它们与在MPO基因高表达的WEHI 3BD +细胞中富集的蛋白质相关;但在两种不表达MPO的淋巴细胞系中则没有。每个元件的位点特异性突变以非累加的方式严重降低了报告基因活性水平。这与体外相应野生型蛋白质 - DNA相互作用的消除或改变情况相似。对增强子中存在的序列基序的分析表明,被定义为体外DNase I足迹的顺式元件可能是新的。